Victory Capital Management Inc. Buys 17,310 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Victory Capital Management Inc. lifted its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 38.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 62,116 shares of the company’s stock after acquiring an additional 17,310 shares during the quarter. Victory Capital Management Inc. owned approximately 0.11% of Astrana Health worth $1,959,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. KBC Group NV purchased a new position in Astrana Health during the 3rd quarter worth $70,000. Quarry LP purchased a new position in shares of Astrana Health during the third quarter valued at $77,000. Quest Partners LLC bought a new stake in shares of Astrana Health in the third quarter valued at about $133,000. Paloma Partners Management Co bought a new stake in shares of Astrana Health in the third quarter valued at about $220,000. Finally, Quantbot Technologies LP purchased a new stake in Astrana Health in the third quarter worth about $244,000. Institutional investors own 52.77% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Stifel Nicolaus cut their target price on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Bank of America cut their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a report on Tuesday, March 4th. Robert W. Baird lowered their target price on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Macquarie upgraded Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Truist Financial decreased their price objective on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $56.83.

Astrana Health Stock Performance

Shares of ASTH stock opened at $30.60 on Tuesday. Astrana Health, Inc. has a 12-month low of $23.12 and a 12-month high of $63.20. The business’s fifty day simple moving average is $33.95 and its 200-day simple moving average is $42.95. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market cap of $1.72 billion, a PE ratio of 23.54, a PEG ratio of 1.37 and a beta of 1.30.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). The business had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. Analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.